欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1262/001
药品名称
Gemcitabin Mylan
活性成分
gemcitabine hydrochloride 10.0 mg/ml
剂型
Concentrate for solution for infusion
上市许可持有人
Mylan Hospital AS Norway
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
许可日期
2013/07/04
最近更新日期
2017/06/28
药物ATC编码
L01BC05 gemcitabine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1262_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1262_001_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase